Honored to present our latest #RomeeLab research on engineering IL-12-secreting CAR NK cells to target high-risk AML—demonstrating feasibility, safety, and efficacy.

What a pleasure to be at #EBMT25 in Florence! 🇮🇹🌞

First-in-human evaluation of memory-like NK cells with an IL-15 super-agonist and CTLA-4 blockade in advanced head and neck cancer - Journal of Hematology & Oncology Background Cytokine induced memory-like natural killer (CIML NK) cells combined with an IL-15 super-agonist (N-803) are a novel modality to treat relapsed/refractory head and neck cancer. Methods We r...

Excited to share this first-in-human evaluation of memory-like NK cells combined with an IL-15 super-agonist, with or without ipilimumab, in advanced head and neck cancer!

Kudos to Roman Shapiro and Michal Sheffer for leading this work in the #RomeeLab.
jhoonline.biomedcentral.com/articles/10....

Thanks @Razan_Mohty for this excellent selection of abstracts on cellular therapy for acute leukemia!

I am excited to also highlight this great study from #RomeeLab which will be presented on Monday, December 9 at #ASH24 by Ji Eun Jang.

ash.confex.com/ash/2024/web... @ash-hematology.bsky.social